Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adnexal Diseases | 1 | 2015 | 30 | 0.510 |
Why?
|
| Premenopause | 1 | 2015 | 131 | 0.500 |
Why?
|
| Genital Neoplasms, Female | 3 | 2018 | 735 | 0.260 |
Why?
|
| Referral and Consultation | 2 | 2015 | 899 | 0.170 |
Why?
|
| Fallopian Tube Neoplasms | 2 | 2017 | 153 | 0.150 |
Why?
|
| Salpingo-oophorectomy | 1 | 2017 | 50 | 0.150 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 353 | 0.140 |
Why?
|
| Peritoneum | 1 | 2017 | 150 | 0.140 |
Why?
|
| Omentum | 1 | 2017 | 96 | 0.140 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 10331 | 0.140 |
Why?
|
| Cyclic S-Oxides | 1 | 2014 | 12 | 0.120 |
Why?
|
| Thiadiazoles | 1 | 2014 | 47 | 0.120 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2014 | 99 | 0.120 |
Why?
|
| Health Status Indicators | 1 | 2014 | 224 | 0.120 |
Why?
|
| Gynecology | 1 | 2015 | 217 | 0.110 |
Why?
|
| Receptor, Notch1 | 1 | 2014 | 218 | 0.110 |
Why?
|
| Intraoperative Complications | 1 | 2014 | 301 | 0.110 |
Why?
|
| Brachytherapy | 1 | 2018 | 977 | 0.100 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2015 | 356 | 0.100 |
Why?
|
| Hysterectomy | 1 | 2014 | 611 | 0.100 |
Why?
|
| Endometrial Neoplasms | 1 | 2020 | 1341 | 0.100 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 622 | 0.090 |
Why?
|
| Uterine Neoplasms | 1 | 2014 | 545 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 622 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 1143 | 0.080 |
Why?
|
| Ultrasonography | 1 | 2015 | 1863 | 0.080 |
Why?
|
| Medical Oncology | 1 | 2015 | 1423 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2014 | 6150 | 0.060 |
Why?
|
| Ovarian Neoplasms | 2 | 2017 | 4638 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2014 | 5542 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 7702 | 0.040 |
Why?
|
| Female | 7 | 2020 | 141928 | 0.040 |
Why?
|
| Aged | 6 | 2020 | 70117 | 0.040 |
Why?
|
| SEER Program | 1 | 2020 | 1000 | 0.040 |
Why?
|
| Fallopian Tubes | 1 | 2017 | 119 | 0.030 |
Why?
|
| Radiotherapy, Image-Guided | 1 | 2018 | 304 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 173 | 0.030 |
Why?
|
| Medicare | 1 | 2020 | 860 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 7789 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2020 | 9244 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 2017 | 358 | 0.030 |
Why?
|
| Genes, BRCA2 | 1 | 2017 | 309 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2015 | 246 | 0.030 |
Why?
|
| Transcription Factor HES-1 | 1 | 2014 | 49 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2017 | 387 | 0.030 |
Why?
|
| BRCA1 Protein | 1 | 2017 | 493 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2018 | 37905 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 2218 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 29902 | 0.030 |
Why?
|
| Humans | 7 | 2020 | 261506 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 309 | 0.030 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2017 | 486 | 0.030 |
Why?
|
| Heart Rate | 1 | 2014 | 737 | 0.020 |
Why?
|
| Adult | 4 | 2018 | 77950 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 10035 | 0.020 |
Why?
|
| Middle Aged | 4 | 2018 | 86204 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 3443 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2014 | 1467 | 0.020 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2018 | 2370 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 3441 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 4298 | 0.020 |
Why?
|
| Survival Rate | 1 | 2020 | 12221 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 5112 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 5395 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 3821 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 13658 | 0.020 |
Why?
|
| United States | 1 | 2020 | 15433 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2014 | 6869 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 17523 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 14551 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 15179 | 0.010 |
Why?
|
| Prognosis | 1 | 2014 | 21713 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 21445 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 11965 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 32848 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 34495 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 15694 | 0.010 |
Why?
|
| Animals | 1 | 2014 | 59536 | 0.010 |
Why?
|